No Copay Physical Therapy Program Associated with Lower Downstream Imaging, Injection, and Surgery for Musculoskeletal Conditions
A program that removes copays for physical therapy is associated with lower rates of costly health care services like imaging, injection, and surgery, according to findings from a new study from ATI Physical Therapy and the Duke Clinical Research Institute (DCRI). The report, “Episode of Care Characteristics following Implementation of a No Co-pay Physical Therapy Program for Musculoskeletal Conditions” was published on October 24 in the Physical Therapy and Rehabilitation Journal and made available on ptfirst.com.
Remote Health Care Helps Heart Failure Patients Get the Right Medications Faster
For millions of Americans living with heart failure, getting the right medications at the right doses can be a slow and frustrating process, which can lead to delayed treatment adjustments, undertreatment and risks for worsening symptoms.
DCRI Podcast "Beyond the Endpoint" Returns for Season 2
The Duke Clinical Research Institute's (DCRI) podcast "Beyond the Endpoint" returns for its second season to address some of the most pressing health questions facing both listeners and the research community.
DCRI faculty share late-breaking study results, lead key discussions on heart health at European Society of Cardiology Congress
Faculty members and fellows of the Duke Clinical Research Institute (DCRI) shared their expertise during the European Society of Cardiology Congress (ESC) in Madrid, Spain, Aug. 29—Sept. 1.
DCRI Accomplishments – Summer 2025
DCRI Accomplishments showcases the publications, awards, and other achievements of our faculty members. Each quarter, a new collection will highlight the most recent accomplishments.
Two-Dose Antibiotic Offers New Hope for Treating Deadly Staph Infections
A new study shows that a simplified two-dose antibiotic treatment may be just as effective as traditional long-term IV therapy for serious staph (staphylococcus) bloodstream infections, offering patients a safer and easier path to recovery.
VictORION INTERVENTION Cardiovascular Outcomes Clinical Trial Enrolls First Participant
A new clinical trial aims to understand whether the early addition of the LDL-cholesterol-lowering medication inclisiran can help reduce cardiac and limb events, such as heart attack, stroke, or amputation, in people who have recently undergone a successful revascularization procedure.
i-Cubed Launches Luminate Insights, Expanding Clinical Research Capacity and Education
i-Cubed, the Duke Clinical Research Institute’s center for clinical research innovation, is excited to introduce Luminate Insights, an education and training platform designed to enhance the capacity and confidence of clinical research professionals across the globe. The platform delivers dynamic, multi-format learning experiences grounded in real-world application, offering a state-of-the-art approach to clinical research education.
Helping Teens Navigate their Neighborhoods Led to Health Gains
A new Duke University School of Medicine study shows that teaching teens how to navigate their neighborhoods – by bus, bike or on foot – can give their health a boost. Durham Parks and Recreation, Durham teens, and pediatric experts at Duke developed a program called Going Places to help kids build the confidence and skills to get around their city.
Study Reveals High Rates of Undiagnosed Heart Failure in Patients with Fatty Liver Disease, Greater Risk for Women
A recent study, led by Duke University researchers and published in the European Journal of Heart Failure, revealed a strikingly high incidence of heart failure (HF) among patients with biopsy-confirmed metabolic dysfunction-associated steatotic liver disease (MASLD), a condition formerly known as non-alcoholic fatty liver disease (NAFLD). The findings suggest that HF is common and underrecognized in the MASLD patient population, raising concerns about missed opportunities for early intervention.